AUA 2009 - Bladder Cancer: Superficial - Hexaminolevulinate Fluorescence Cystoscopy Improves Detection and Resection of Papillary Bladder Cancer Lesions and Reduces Early Recurrences - Session Highlights
Thursday, 30 April 2009
CHICAGO, IL, USA (UroToday.com) - This study sought to compare fluorescence guided and white light cystoscopy in the detection of non-muscle invasive papillary bladder tumors, and to compare early recurrence rates following HAL or white light resection of identified tumors.
Login to read more...
|
AUA 2009 - Bladder Cancer: Superficial - Racial Differences in Treatment and Outcomes Among Patients with Early Stage Bladder Cancer - Session Highlights
Thursday, 30 April 2009
CHICAGO, IL, USA (UroToday.com) - This study explored the extent to which disparities in mortality are attributable to the urologist among patients with early stage bladder cancer.
Login to read more...
|
AUA 2009 - A Review of AUA Clinical Guidelines on the Management of Non-Muscle Invasive Bladder Cancer - Session Highlights
Wednesday, 29 April 2009
CHICAGO, IL, USA (UroToday.com) - A panel on non-muscle invasive bladder cancer (NMIBC) was moderated by Dr. Mark Soloway.
Login to read more...
|
AUA 2009 - Bladder Cancer: Superficial - Intraoperative Stenting of the Upper Urinary Tract is not Necessary After Resection of the Ureteric Orifice During Transurethral Resection of the Bladder - Session Highlights
Wednesday, 29 April 2009
CHICAGO, IL, USA (UroToday.com) - These researchers evaluated the common practice of placing a double J stent when transurethral resection of a bladder tumor (TUR-B) includes resection of the ureteric orifice.
Login to read more...
|
AUA 2009 - Bladder Cancer: Superficial - NMP22 is Predictive of Recurrence in High Risk Superficial Bladder Cancer Patients - Session Highlights
Wednesday, 29 April 2009
CHICAGO, IL, USA (UroToday.com) - This study assessed the use of NMP22 to predict which high-risk superficial bladder cancer patients will have recurrence, progression or disease-related death and compared this to standard urine cytology.
Login to read more...
|
AUA 2009 - Bladder Cancer: Invasive Metastatic Disease - Significance of Distal Ureteral Margin at Radical Cystectomy for Urothelial Carcinoma - Session Highlights
Wednesday, 29 April 2009
CHICAGO, IL, USA (UroToday.com) - Patients undergoing radical cystectomy are at risk for upper tract recurrence.
Login to read more...
|
AUA 2009 - Bladder Cancer: Invasive Metastatic Disease - Detection of Circulating Tumour Cells with the Cellsearch System® in Peripheral Blood from Patients with Advanced Bladder Cancer - Session Highlights
Wednesday, 29 April 2009
CHICAGO, IL, USA (UroToday.com) - The CellSearch System®(CSS) is a new automated, standardized enrichment and
immunocytochemical detection system for circulating tumor cells (CTCs) in the peripheral blood.
Login to read more...
|
AUA 2009 - NMP22 is Predictive of Recurrence in High-Risk Superficial Bladder Cancer Patients - Session Highlights
Wednesday, 29 April 2009
CHICAGO, IL, USA (UroToday.com) - In this report, the authors suggests that NMP22 might be useful for predicting which patients will have future tumor recurrence but not progression or survival.
Login to read more...
|
AUA 2009 - Bladder Cancer: Basic Research - Effects of mTOR Inhibitor Everolimus (RAD001) on Bladder Cancer Cells - Session Highlights
Tuesday, 28 April 2009
CHICAGO, IL, USA (UroToday.com) - This presentation reported on the effect of the mTOR inhibitor everolimus (RAD001) on human bladder cancer cells in vitro and in vivo.
Login to read more...
|
AUA 2009 - Bladder Cancer: Basic Research - Quantification of Sunitinib's Antitumor Effects in a Localized Orthotopic Bladder Cancer Model - Session Highlights
Tuesday, 28 April 2009
CHICAGO, IL, USA (UroToday.com) - This study reported on the effects of sunitinib on tumor growth rate, tumor volume, and vascular endothelial growth factor (VEGF) receptor (VEGFR2) expression in an orthotopic mouse bladder cancer model.
Login to read more...
|
AUA 2009 - Bladder Cancer: Detection and Screening - Molecular Tumor Marker Tests for Bladder Cancer Screening are Influenced by Various Confounders - Interim Data of the Prospective Study UroScreen - Session Highlights
Tuesday, 28 April 2009
CHICAGO, IL, USA (UroToday.com) - This presentation was on UroScreen, a prospective study for early diagnosis of bladder cancer in 1,772 chemical workers formerly exposed to aromatic amines.
Login to read more...
|
AUA 2009 - Bladder Cancer: Detection and Screening - Combinations of Several Urinary Tumour Markers Can Reduce Follow-up Cystoscopies in Transitional Cell Carcinoma Patients - Session Highlights
Tuesday, 28 April 2009
CHICAGO, IL, USA (UroToday.com) - The aim of this presentation was to investigate if a combination of several tumor markers might be used to safely reduce the number of cystoscopies in patients with transitional cell carcinoma (TCC).
Login to read more...
|
AUA 2009 - Bladder Cancer: Basic Research - The FGFR3 Mutation is Related to Favorable pT1 Bladder Cancer - Session Highlights
Monday, 27 April 2009
CHICAGO, IL, USA (UroToday.com) - This group of investigators sought to determine the frequency of fibroblast growth factor receptor 3 (FGFR3) mutations in a group of primary pT1 bladder cancer tumors (BC) and correlate the FGFR3 mutation to various histo-pathological variables.
Login to read more...
|
AUA 2009 - Bladder Cancer: Basic Research - Absence of CD44 Expression is an Independent Predictor of Poor Outcome for Patients with Urothelial Bladder Cancer - Session Highlights
Monday, 27 April 2009
CHICAGO, IL, USA (UroToday.com) - This presentation reported on CD44 expression in bladder cancer and its association with survival.
Login to read more...
|
AUA 2009 - Bladder Cancer: Basic Research - Combinational p53 and Pten Inactivation Promotes Invasive Bladder Cancer - Session Highlights
Monday, 27 April 2009
CHICAGO, IL, USA (UroToday.com) - This group of investigators from Columbia University have previously revealed distinct genotypic and phenotypic patterns associated with non muscle-invasive versus muscle-invasive bladder cancer.
Login to read more...
|
AUA 2009 - Bladder Cancer: Basic Research - Clinical Significance of False Positive Mucosa by Photodynamic Diagnosis-Possible Existence of Premalignant Genomic Alterations - Session Highlights
Monday, 27 April 2009
CHICAGO, IL, USA (UroToday.com) - Photodynamic diagnosis (PDD) by the fluorescence cystoscopy has become a novel tool not only for decreasing the recurrence in non-invasive bladder cancer.
Login to read more...
|
AUA 2009 - Combinations of Several Urinary Tumour Markers Can Reduce Follow-up Cystoscopies in Transitional Cell Carcinoma Patients - Poster
Monday, 27 April 2009
CHICAGO, IL, USA (UroToday.com) - The aim of this study was to investigate if a combination of several tumour markers might be used to safely reduce the number of cystoscopies in transitional cell carcinoma (TCC) patients.
Login to read more...
|
AUA 2009 - Bladder Cancer: General & Epidemiological Trends & Socioeconomics: Unnecessary Consultation and Evaluation in Patient with Pseudohematuria: An Analysis of Referral Patterns for Asymptomatic Hematuria - Session Highlights
Monday, 27 April 2009
CHICAGO, IL, USA (UroToday.com) - Screening for bladder cancer is often practiced by Primary Care Providers (PCP’s), although it is not recommended by major health care organizations.
Login to read more...
|
AUA 2009 - New Approaches to Management of Cancer Invasiveness: Personalized Therapy and Drug Discovery in Urologic Cancer - Session Highlights
Tuesday, 28 April 2009
CHICAGO, IL, USA (UroToday.com) - Dr. Dan Theodorescu presented the concept of personalized cancer therapy.
Login to read more...
|
AUA 2009 - Urothelial Cancer: Surgical Therapy - BMI and Age are Independent Predictors of Postoperative Ileus Following Radical Cystectomy with Pelvic Lymphadenectomy - Session Highlights
Monday, 27 April 2009
CHICAGO, IL, USA (UroToday.com) - The aim of this study was to identify potential preoperative features that would aid in the identification of patients at highest risk for developing post-operative ileus.
Login to read more...
|
AUA 2009 - Urothelial Cancer: Surgical Therapy - Removal of at Least 8 Nodes Improves Cancer Specific Survival in Non Metastatic Patients with Upper Tract Urothelial Carcinoma - Session Highlights
Monday, 27 April 2009
CHICAGO, IL, USA (UroToday.com) - This large multi-institutional research consortium sought to establish a minimum number of lymph nodes (LN) that should be removed to improve cancer-specific survival (CSS) in patients with urothelial carcinoma of the upper urinary tract (UTUC) managed with radical nephroureterectomy (RNU) and lymph node dissection.
Login to read more...
|
AUA 2009 - Urothelial Cancer: Upper Tract Tumors - Troubling Outcomes from a Population Level Analysis of Surgery for Upper Tract Urothelial Carcinoma - Session Highlights
Monday, 27 April 2009
CHICAGO, IL, USA (UroToday.com) - The aim of this study was to review the surgical management of upper tract urothelial carcinoma (UTUC) on a population level to determine if sub-optimal surgical technique is associated with an adverse prognosis.
Login to read more...
|
AUA 2009 - Urothelial Cancer: Upper Tract Tumors - Patterns and Predictors of Urothelial Recurrence Following Nephroureterectomy for Upper Tract Tumors - Session Highlights
Monday, 27 April 2009
CHICAGO, IL, USA (UroToday.com) - These authors report on the incidence, clinicopathologic features, and predictors of recurrent tumors after nephroureterectomy (NU) for upper tract urothelial carcinoma (UTUC) in patients with no prior history of bladder cancer.
Login to read more...
|
AUA 2009 - Myoblasts Can Form New Muscle Tissue and Induce Angio-and Neurogenisis - Session Highlights
Monday, 27 April 2009
CHICAGO, IL, USA (UroToday.com) - In this report, Dr. Hannes Strasser presented work from Austria which suggests that myoblasts have the capacity to form new muscle tissue in vitro and induce angiogenesis and neurogeneis.
Login to read more...
|
AUA 2009 - Bladder & Urethra: Anatomy, Physiology and Pharmacology - Myoblasts Can Form New Muscle Tissue and Induce Angio-And Neurogenesis - Session Highlights
Monday, 27 April 2009
CHICAGO, IL, USA (UroToday.com) - Much focus is on the ability of stem cells to differentiate into other tissue types.
Login to read more...
|
AUA 2009 - Veterans with Nonmuscle-Invasive Bladder Cancer Report Worse HRQOL than Private Patients - Session Highlights
Monday, 27 April 2009
CHICAGO, IL, USA (UroToday.com) - In this report, Dr. Sai Munjampalli et al. presented preliminary data from an ongoing study suggesting that veterans have poorer health-related quality of life (HRQOL) than private patients.
Login to read more...
|
AUA 2009 - Unnecessary Consultation and Evaluation in Patient with Pseudohematuria: An Analysis of Referral Patterns for Asymptomatic Hematuria - Session Highlights
Monday, 27 April 2009
CHICAGO, IL, USA (UroToday.com) - This report suggests that many patients with asymptomatic hematuria undergo unnecessary consultation and evaluation.
Login to read more...
|
AUA 2009 - State-of-the-Art Lecture – Enterocystoplasty: What is the Risk of Malignancy? - Session Highlights
Monday, 27 April 2009
CHICAGO, IL, USA (UroToday.com) -
Risk of malignancy exists after augmentation.
Login to read more...
|
AUA 2009 - Delays in Bladder Cancer Diagnosis and Survival - Session Highlights
Sunday, 26 April 2009
CHICAGO, IL, USA (UroToday.com) - In this report from University of Michigan investigators, the authors added to the body of literature which suggests that a delay in diagnosis leads to increase risk of bladder cancer death.
Login to read more...
|
AUA 2009 - Ethnic Differences in Bladder Cancer Survival - Session Highlights
Sunday, 26 April 2009
CHICAGO, IL, USA (UroToday.com) - In this report, Dr. David Yee, et al. from New York studied the SEER database and showed that African Americans have an increased rate of death from bladder cancer compared to whites, Hispanics and Asian Pacific Americans.
Login to read more...
|
AUA 2009 - Beyond the AUA Guidelines for the Management of Non-Muscle Invasive Bladder Cancer - SUO Meeting - Session Highlights
Saturday, 25 April 2009
CHICAGO, IL, USA (UroToday.com) - The group of panelists, led by Dr. Sam Chang, first discussed recurrent CIS after induction BCG.
Login to read more...
|
AUA 2009 - Société Internationale d’Urologie (SIU) Lecture - Lymph Node Dissection in Urologic Cancers: Treatment or Staging Only - Session Highlights
Tuesday, 28 April 2009
CHICAGO, IL, USA (UroToday.com) - Professor Joachim Thuroff discussed lymph node dissection (LND) in urologic cancers.
Login to read more...
|
AUA 2009 - Current Status of Node Dissection in Urologic Cancer: T1-3, N0 Bladder Cancer - SUO Meeting - Session Highlights
Saturday, 25 April 2009
CHICAGO, IL, USA (UroToday.com) - Dr. Peter Clark of Vanderbilt University opened his presentation by defining lymph node (LN) density as the number of positive lymph nodes divided by the number removed.
Login to read more...
|
AUA 2009 - Intravesical BCG Therapy, Lessons Learned from History and Clinical Investigation - SUO Meeting - Session Highlights
Saturday, 25 April 2009
CHICAGO, IL, USA (UroToday.com) - Dr. Harry Herr of the Memorial Sloan-Kettering Cancer Center
was honored with the Whitmore medal and his lecture was titled “Intravesical BCG Therapy, Lessons Learned from History and Clinical Investigation.”
Login to read more...
|
AUA 2009 - NMP22 is Predictive of Recurrence in High Risk Superficial Bladder Cancer Patients - Poster
Tuesday, 28 April 2009
CHICAGO, IL, USA (UroToday.com) - We assessed the use of urinary NMP22 to predict
which high risk superficial UC patients will have recurrence, progression or disease related death and compared this to standard urine cytology.
Login to read more...
|
Conference Coverage 
